Prostate Cancer - Results from #21340

Clinical features and management of BRCA1 and BRCA2-associated prostate cancer - Abstract February 1, 2014

Use of intravenous bisphosphonates in patients with breast, lung, or prostate cancer and metastases to bone: a 15-year study in two large US health systems - Abstract February 1, 2014

Clinical and demographic factors associated with receipt of non guideline-concordant initial therapy for nonmetastatic prostate cancer - Abstract February 1, 2014

Obesity has multifaceted impact on biochemical recurrence of prostate cancer: A dose-response meta-analysis of 36,927 patients - Abstract February 1, 2014

Hormonal therapy for prostate cancer: Methods and prognosis - Abstract January 31, 2014

A dual model HU conversion from MRI intensity values within and outside of bone segment for MRI-based radiotherapy treatment planning of prostate cancer - Abstract January 31, 2014

Treatment planning for prostate focal laser ablation in the face of needle placement uncertainty - Abstract January 31, 2014

Multiparametric magnetic resonance imaging for the assessment of extracapsular invasion and other staging parameters in patients with prostate cancer candidates for radical prostatectomy - Abstract January 31, 2014

GU Cancers Symposium 2014 - A decade in review for radiotherapy of prostate cancer - Session Highlights January 31, 2014

Long-term outcomes of dynamic conformal arc irradiation combined with neoadjuvant hormonal therapy in japanese patients with T1c-T2N0M0 prostate cancer: Case series study - Abstract January 30, 2014

Does transperitoneal minimally invasive radical prostatectomy increase the amount of small bowel receiving salvage radiation? - Abstract January 30, 2014

Utility of 5-alpha-reductase inhibitors in active surveillance for favourable risk prostate cancer - Abstract January 30, 2014

Low-dose rate brachytherapy for patients with low- or intermediate-risk prostate cancer: A systematic review - Abstract January 30, 2014

Comparative effectiveness study of patient-reported outcomes after proton therapy or intensity-modulated radiotherapy for prostate cancer - Abstract January 30, 2014

Clinical activity and tolerability of enzalutamide (MDV3100) in patients with metastatic, castration-resistant prostate cancer who progress after docetaxel and abiraterone treatment - Abstract January 30, 2014

Concordance between administrative claims and registry data for identifying metastasis to the bone: an exploratory analysis in prostate cancer - Abstract January 30, 2014

Type 2 diabetes and the risk of mortality among patients with prostate cancer - Abstract January 30, 2014

Prevention and treatment of biopsy-related complications - Abstract January 30, 2014

Adjuvant radiotherapy after prostatectomy for prostate cancer in Japan: A multi-institutional survey study of the JROSG - Abstract January 30, 2014

A Phase II study of salvage high-dose-rate brachytherapy for the treatment of locally recurrent prostate cancer after definitive external beam radiotherapy - Abstract January 29, 2014

Page 1068 of 1436